Rakuten Securities Inc. Has $1.55 Million Stock Holdings in Astera Labs, Inc. $ALAB

Rakuten Securities Inc. raised its stake in Astera Labs, Inc. (NASDAQ:ALAB) by 37.9% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 9,312 shares of the company’s stock after purchasing an additional 2,557 shares during the period. Rakuten Securities Inc.’s holdings in Astera Labs were worth $1,549,000 at the end of the most recent quarter.

Other large investors also recently modified their holdings of the company. Perigon Wealth Management LLC boosted its holdings in shares of Astera Labs by 6.2% during the 4th quarter. Perigon Wealth Management LLC now owns 1,252 shares of the company’s stock worth $208,000 after buying an additional 73 shares during the period. Clearstead Advisors LLC boosted its holdings in shares of Astera Labs by 13.6% during the third quarter. Clearstead Advisors LLC now owns 636 shares of the company’s stock worth $125,000 after acquiring an additional 76 shares during the period. Sound Income Strategies LLC grew its position in shares of Astera Labs by 9.2% in the fourth quarter. Sound Income Strategies LLC now owns 902 shares of the company’s stock valued at $164,000 after purchasing an additional 76 shares during the last quarter. Venturi Wealth Management LLC grew its position in shares of Astera Labs by 2.6% in the fourth quarter. Venturi Wealth Management LLC now owns 3,284 shares of the company’s stock valued at $546,000 after purchasing an additional 84 shares during the last quarter. Finally, Great Valley Advisor Group Inc. increased its stake in shares of Astera Labs by 2.2% during the second quarter. Great Valley Advisor Group Inc. now owns 4,119 shares of the company’s stock worth $372,000 after purchasing an additional 90 shares during the period. 60.47% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several analysts recently issued reports on ALAB shares. Loop Capital initiated coverage on Astera Labs in a research note on Thursday, March 5th. They issued a “buy” rating and a $250.00 price target for the company. Weiss Ratings downgraded Astera Labs from a “hold (c-)” rating to a “sell (d+)” rating in a report on Monday, February 23rd. Royal Bank Of Canada reissued an “outperform” rating and issued a $250.00 target price on shares of Astera Labs in a research report on Tuesday. Barclays set a $165.00 price target on shares of Astera Labs in a research report on Thursday, January 15th. Finally, UBS Group started coverage on shares of Astera Labs in a research note on Tuesday. They issued a “neutral” rating and a $180.00 price objective for the company. Fifteen equities research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $199.74.

Insiders Place Their Bets

In related news, CEO Jitendra Mohan sold 10,188 shares of the firm’s stock in a transaction dated Monday, April 20th. The stock was sold at an average price of $175.45, for a total value of $1,787,484.60. Following the sale, the chief executive officer directly owned 4,069,134 shares of the company’s stock, valued at $713,929,560.30. This trade represents a 0.25% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Manuel Alba sold 183,000 shares of the firm’s stock in a transaction that occurred on Wednesday, April 1st. The shares were sold at an average price of $107.61, for a total transaction of $19,692,630.00. Following the completion of the sale, the director owned 319,863 shares in the company, valued at approximately $34,420,457.43. The trade was a 36.39% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 1,064,888 shares of company stock valued at $150,764,723 in the last quarter. Corporate insiders own 12.50% of the company’s stock.

Astera Labs Stock Up 1.8%

Shares of Astera Labs stock opened at $197.54 on Friday. Astera Labs, Inc. has a 12-month low of $61.18 and a 12-month high of $262.90. The company has a market capitalization of $33.83 billion, a price-to-earnings ratio of 161.92, a PEG ratio of 3.82 and a beta of 1.78. The firm’s 50-day moving average price is $132.20 and its two-hundred day moving average price is $154.08.

Astera Labs (NASDAQ:ALAB) last issued its earnings results on Tuesday, February 10th. The company reported $0.58 EPS for the quarter, beating the consensus estimate of $0.51 by $0.07. Astera Labs had a net margin of 25.70% and a return on equity of 16.12%. The company had revenue of $270.58 million during the quarter, compared to analysts’ expectations of $249.46 million. During the same period in the previous year, the company earned $0.37 EPS. The business’s revenue for the quarter was up 91.8% compared to the same quarter last year. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. On average, sell-side analysts expect that Astera Labs, Inc. will post 1.48 earnings per share for the current year.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.